Cargando…
The Safety of Anti-SARS-CoV-2 Vaccines: Vigilance Is Still Required
The opinion I put forward in this paper is that attention must continue to be paid to clinical observations compatible with a detrimental effect of anti-SARS-CoV-2 in certain diseases of immunological nature. Using the example of the atypical thrombocytopenic thromboses caused by adenoviral-vector-b...
Autor principal: | Goldman, Michel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910899/ https://www.ncbi.nlm.nih.gov/pubmed/35268339 http://dx.doi.org/10.3390/jcm11051248 |
Ejemplares similares
-
SARS-CoV-2 vaccination in liver transplant recipients: We still haven't found what we are looking for
por: Thompson, Marcos A., et al.
Publicado: (2023) -
Anti-SARS-CoV-2 Antibodies Testing in Recipients of COVID-19 Vaccination: Why, When, and How?
por: Lippi, Giuseppe, et al.
Publicado: (2021) -
Upper respiratory tract mucosal immunity for SARS-CoV-2 vaccines
por: Fraser, Rupsha, et al.
Publicado: (2023) -
SARS-CoV-2 Vaccines: Inactivation by Gamma Irradiation for T and B Cell Immunity
por: Mullbacher, Arno, et al.
Publicado: (2020) -
Can live-attenuated SARS-CoV-2 vaccine contribute to stopping the pandemic?
por: Tang, Patrick Chun Hean, et al.
Publicado: (2022)